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Worldwide, more than 7 million children have now been born after ART: these delivery rates are 
steadily rising and now comprise 2-6% of births in the European countries. To achieve higher 
pregnancy rates, the transfer of two or more embryos was previously the gold standard in ART. 
However, recently the practise has moved towards a single embryo transfer policy to avoid multiple 
births. The positive consequences of the declining multiple birth rates after ART are decreasing 
perinatal risks and overall improved health for the ART progeny. In this review we summarize the 
risks for short- and long-term health in ART singletons and discuss if the increased health risks are 
associated with intrinsic maternal or paternal factors related to subfertility or to the ART treatments 
per se. 
Although the risks are modest, singletons born after ART are more likely to have adverse perinatal 
outcomes compared to spontaneously conceived (SC) singletons dependent on the ART method. 
Fresh embryo transfer is associated with a higher risk of small for gestational age babies (SGA), 
low birthweight and preterm birth (PTB), while frozen embryo transfer is associated with large-for-
gestational age babies and pre-eclampsia. ICSI may be associated with a higher risk of birth 
defects and transferral of the poor semen quality to male progeny, while oocyte donation is 
associated with increased risk of SGA and pre-eclampsia. Concerning long-term health risks, the 
current evidence is limited but suggests an increased risk of altered blood pressure and 
cardiovascular function in ART children. The data that are available for malignancies seem 
reassuring, while results on neurodevelopmental health are more equivocal with a possible 
association between ART and cerebral palsy. The laboratory techniques used in ART may also 
play a role, as different embryo culture media give rise to different birthweights and growth patterns 
in children, while culture to blastocyst stage is associated with PTB. In addition, children born after 
ART have altered epigenetic profiles, and these alterations may be one of the key areas to explore 
to improve our understanding of adverse child outcomes after ART.   
A major challenge for research into adverse perinatal outcomes is the difficulty in separating the 
contribution of infertility per se from the ART treatment (i.e. “the chicken or the egg”?). Choosing 
and having access to the appropriate control groups for the ART children in order to eliminate the 
influence of subfertility per se (thereby exploring the pure association between ART and child 
outcomes) is in itself challenging. However, studies including children of subfertile couples or of 
couples treated with milder fertility treatments, such as IUI, as controls show that perinatal risks in 
these cohorts are lower than for ART children but still higher than for SC indicating that both 
subfertility and ART influence the future outcome. Sibling studies, where a mother gave birth to 
both an ART and a SC child, support this theory as ART singletons had slightly poorer outcomes.  
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The conclusion we can reach from the well designed studies aimed at disentangling the influence 
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Worldwide, more than 7 million children have now been born after ART (Adamson G. 2017). The 
health of ART offspring and the risk and safety aspects of specific ART technologies are of 
importance for the future generations as up to 6% of the European birth cohorts is conceived by 
ART (Calhaz-Jorge et al. 2017). ART includes standard IVF and ICSI, which is the more advanced 
method originally used for severe male factor infertility. The freezing and thawing of embryos is an 
additional part of ART, as is oocyte donation (OD). Pregnancies resulting from ART are generally 
associated with adverse obstetric and perinatal outcomes when compared to spontaneously 
conceived (SC) pregnancies (Helmerhorst et al. 2004; Pinborg et al. 2013; Adams et al. 2015) 
mainly related to the higher rate of multiple gestations. However, the decline in multiple birth rates 
after ART resulting from a move towards single embryo transfer (SET) has considerably reduced 
perinatal risks for ART children (Henningsen et al. 2015). Yet, singletons born after ART have a 
two- to three-fold increased risk of adverse perinatal outcomes (McDonald et al. 2009; Pandey et 
al. 2012).   
A major challenge for research into these adverse outcomes is the difficulty in separating the 
contribution of infertility per se from the ART treatment (i.e. “the chicken or the egg”). Furthermore, 
in order to compare the health of children born after a natural pregnancy with that of children born 
after ART, an accurate assessment of the evidence is required, including the quality of that 
evidence. Selecting an appropriate comparison group(s) for children born after ART is vital, and 
this is a challenge. In most studies, SC children comprise the control group, but it is debatable 
whether this is the correct group. If parental factors such as infertility per se influence health of the 
offspring, then children conceived naturally by subfertile parents [with a time-to-pregnancy (TTP) of 
more than 1 year], may constitute a more appropriate control group. Children born after mild 
ovarian stimulation and IUI could also serve as a better group for comparison. These control 
groups are, however, difficult to access and most often not included in any registry. To overcome 
the confounding of parental factors, sibling studies, where a woman gave birth to both a child 
conceived by ART and a SC child, are valuable. The pure influence of different ART methods can 
be explored, as several parental factors are kept stable in sibling studies (Romundstad et al. 2008; 
Henningsen et al. 2011). The pitfalls in sibling studies are that they may still be confounded by 
differences in maternal age and birth order of the siblings, unless these factors are being properly 
adjusted for.  
Possible changes in DNA methylation patterns associated with different ART methods may 
influence development of the placenta and foetus in the early embryonic stages and cause 
changes in growth patterns. According to the developmental origins of health and disease 
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(DOHaD) theory, this may result in higher cardiometabolic risk profiles in the ART offspring (Barker 
2007).  
It is evident that the high rate of multiple births from multiple embryo transfer is the most important 
cause of poor child outcome in ART (Bergh et al. 1999; Pinborg et al. 2005). Moreover, SET 
decreases the short- and long-term risks for the children dramatically, while giving similar live birth 
rates as double embryo transfer (DET) on a cumulative basis (Thurin et al. 2004; Thurin-Kjellberg 
et al. 2009).  
In this grand theme review, we will focus on ART singletons, summarizing the short- and long-term 
risks in singletons conceived by ART, including IVF, ICSI, freezing/thawing and OD (The definitions 
of all abbreviations used in the review are shown in Table I.) Children conceived by MAR, including 
IUI, PGD and preimplantation genetic testing for aneuploidy, were all excluded. The influence of 
different parental lifestyle factors will not be described here. The discussion is focused on studies 
aiming to disentangle the different modulators of adverse outcomes in ART singletons, including a 
discussion on causality in terms of “the chicken or the egg” question.  
 
Methods 
A literature search was performed on Medline-PubMed, Embase and Cochrane Central 
Register of Clinical Trials (RCT) to identity eligible English language studies.  
The reference lists of relevant articles were reviewed to identify additional qualified 
studies. No formal quality assessments where made.  
 
Short-term health: perinatal outcomes 
IVF/ICSI versus the general population 
Several meta-analyses and large cohort studies have compared perinatal outcomes for IVF 
singletons versus singletons from the general population of naturally conceived children, with 
adjustment for relevant confounders (at least maternal age and parity) (Helmerhorst et al. 2004; 
Jackson et al. 2004; McGovern et al. 2004; McDonald et al. 2009; Pandey et al. 2012; Marino et al. 
2014; Henningsen et al. 2014; Qin et al. 2017). Most studies have included both children born after 
IVF and ICSI as well as fresh embryo transfer and frozen embry transfer (FET). The comparison 
groups have been children born from SC, but some studies included only SC in a subfertile 
population as controls, while others excluded the subfertile population. The latest systematic 
review and meta-analysis from 2017 included more than 180,000 IVF/ICSI singleton pregnancies 
from 52 cohort studies from all over the world (Qin et al. 2017). 
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The results from these studies are consistent, showing that singletons born after IVF/ICSI have 
more compromised perinatal outcomes compared to SC (Fig. 2). Significantly higher rates of 
preterm birth (PTB) have been found for IVF/ICSI singletons with adjusted risks between 1.41 and 
2.04 for PTB and 1.68-3.07 for very preterm birth (VPTB). Similarly, higher rates of low birthweight 
(LBW) and very low birth weight (VLBW) have been found (adjusted risks for LBW 1.6-1.7 and for 
VLBW 1.8-3.0). Most studies also found an increased risk for being born small for gestational age 
(SGA) with adjusted risks of around 1.5 and increased risk rates of perinatal mortality with adjusted 
risks between 1.7 and 2.0.  An Australian study found a two-fold increased risk of stillbirth 
(gestational age [GA] not defined) in pregnancies after ART versus SC (Marino et al. 2014). A 
significantly increased risk for stillbirth in ART singletons was found only for extremely PTB (before 
28+0 gestational weeks) in a large Nordic collaborative study (Committee of Nordic ART and 
Safety, CoNARTaS) including 62,485 ART singletons (adjusted risk 2.0) (Henningsen et al. 2014).  
ART pregnancies have more obstetric complications, such as hypertensive disorders in pregnancy 
(HDP), placental complications (placenta praevia, abruption and third trimester bleeding), 
gestational diabetes, interventions (e.g. cesarean section and medical induction of labour) and 
increased risks of preterm prelabour rupture of the membranes, indicating that there is both a 
higher risk of indicated PTB and a higher risk of spontaneous PTB in ART pregnancies (Pandey et 




IVF versus ICSI 
Since the first child conceived as a result of ICSI was born more than 25 years ago there has been 
an ongoing debate on the use and safety of the technique (Palermo et al. 1992). Initially, ICSI was 
used to treat severe forms of male factor infertility but today it is also used to treat mild male factor 
infertility, mixed infertility, unexplained infertility and fertilization failures. Both the latest report from 
ESHRE and from The International Committee Monitoring Assisted Reproductive Technologies 
(ICMART) reveal an increasing global use of ICSI, with one-third of fresh ART cycles using 
standard IVF and two-thirds using ICSI (Dyer et al. 2016; Calhaz-Jorge et al. 2017). Owing to the 
invasiveness of the ICSI procedure, the arbitrary selection of the spermatozoon, and genetic and 
epigenetic parental factors, a concern has been raised over the health of ICSI children.  
When comparing ICSI and standard IVF, most large studies have found similar or lower risks of 
PTB, VPTB, LBW and VLBW and peri/neonatal mortality in singletons born after ICSI. 
Pinborg et al analysed singletons born after ICSI (fresh or frozen/thawed cycles) versus singletons 
born after IVF (fresh or frozen/thawed cycles) (Pinborg et al. 2013). Ten studies were included in 
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the analysis with five studies included in a meta-analysis on PTB. The pooled estimate for ICSI 
versus IVF singletons showed a lower risk of PTB in ICSI singletons (adjusted odds ratio (AOR) 
0.80, 95% CI 0.69 to 0.93).  
A possible explanation for the better outcome in ICSI singletons may be that in ICSI the majority of 
the women are reproductively healthy, which could give a more favourable perinatal outcome.  
 
 
IVF/ICSI fresh versus IVF/ICSI frozen/thawed embryo transfer   
The first human pregnancy following the transfer of a frozen/thawed embryo was reported in 1983 
(Trounson and Mohr 1983). The number of FETs has now increased, as have pregnancy rates 
(Calhaz-Jorge et al. 2017). Initial systematic reviews and meta-analyses have suggested that 
perinatal outcomes are better in children conceived following FET as compared with fresh embryo 
transfers (ET), with reduced risks of PTB and LBW (Wennerholm et al. 2009; Maheshwari et al. 
2012; Pinborg et al. 2013; Zhao et al. 2016). There was no difference in the risk of stillbirth and 
perinatal mortality. These reviews did not include outcomes such as macrosomia and large for 
gestational age (LGA). 
Maheshwari et al recently published an updated systematic review and cumulative meta-analysis 
(Maheshwari et al. 2018) including 26 studies and almost 300,000 deliveries.  It confirmed that 
singletons conceived from FET were at lower risk of PTB (Relative Risk (RR) 0.90, 95% CI 0.84 to 
0.97), LBW (RR 0.72, 95% CI 0.67 to 0.77) and SGA (RR 0.61, 95% CI 0.56 to 0.67) compared to 
those conceived from fresh ET. However, they also found that singletons born after FET had an 
increased risk of being born LGA (RR 1.54, 95% CI 1.48 to1.61) and having a birthweight (BW) 
more than 4000 g (RR 1.85, 95% CI 1.46 to 2.33). There was no difference in the risk of perinatal 
mortality between children born after FET and fresh ET but the risk of HDP was increased (RR 
1.29, 95% CI 1.07 to 1.56) in pregnancies after FET (Maheshwari et al. 2018).   
Vitrification is an ultrarapid cryopreservation method, which has superseded slow freezing as the 
dominant method for cryopreservation in recent years. It has been associated with higher post-
thaw survival rates and clinical pregnancy rates when compared to slow freezing (AbdelHafez et al. 
2010; Rienzi et al. 2017). However, the high concentrations of cryoprotectants used for vitrification 
have raised concerns about possible negative health effects for the children. When comparing 
vitrification and slow freezing of day 3 embryos or blastocysts, a similar or slightly better outcome 




The implications of the findings of macrosomia and LGA after FET and the consequences for 
childhood health and risk of obesity are unclear and more follow-up studies are needed. Different 
explanations for this over-growth have been suggested. It may be a selection process with higher 
quality embryos surviving the freezing and thawing procedure.  Another possible explanation is that 
the cryopreservation technique may cause epigenetic modifications (heritable alterations that are 
not caused by changes in DNA sequence but by modifications, such as DNA methylation) at the 
early embryonic stages and hence in the growth potential of the foetus. A third suggested 
explanation is that the uterine environment in a FET cycle results in a more natural uterine 
environment, as the ovarian stimulation used in a fresh IVF cycle is not used in most FET cycles.  
Recently, the shift to a ‘freeze all’ strategy in an increasing number of ART treatments in 
preference to the conventional policy of fresh ET has caused attention. Three large randomised 
controlled trials (RCTs) have recently been published (Chen et al. 2016; Shi et al. 2018; Vuong et 
al. 2018). In the Chen et al study (n=1508 women), the transfer of vitrified embryos resulted in 
higher live birth rates than the transfer of fresh embryos in women with infertility associated with 
polycystic ovary syndrome (PCOS). In the two other RCTs (n=2157 and n=782 women, 
respectively), which included ovulatory women with no PCOS, the live birth rates were similar in 
both groups. A higher mean BW was found in the FET group in two of the three RCTs (Chen et al. 
2016; Vuong et al. 2018) and fewer neonates were born SGA in the FET group in one study 




Trends over time in perinatal outcomes 
Recently, a study of the perinatal outcome of 62,379 ART singletons born between 1988 and 2007 
in four Nordic countries from the CoNARTaS (AUTHOR: can this name be defined?- it is defined in 
the above text in line 241) group was published (Henningsen et al. 2015). The ART singletons 
were compared with a control group of 362,215 SC singletons. The rates of several adverse 
perinatal outcomes were stratified into the following time periods: 1988–1992, 1993–1997, 1998–
2002 and 2003–2007. For singletons conceived after ART but not for singletons born after SC, a 
substantial decline in the risk of PTB and VPTB was observed. The proportion of ART singletons 
born with LBW and VLBW also decreased, as well as the stillbirth and infant death rates. There are 
several possible explanations for the positive development such as a change in the number of 
women seeking ART with a shorter duration of infertility, more ICSI/male factor and fewer embryos 





Singletons born after ART have worse perinatal outcomes compared with singletons born after SC. 
However, these differences are less pronounced for children born after ICSI and FET and show a 
clear trend of improved outcomes during recent years. 
 
 
Birth defects and chromosomal anomalies 
Classification of birth defects 
When reporting birth defects, different classification methods have been used. Major birth defects 
could be defined as causing functional impairment or requiring surgical correction. This is the 
classification used by Bonduelle and coworkers in their follow-up studies of ART infants (Bonduelle 
et al. 2005). However, the definition is problematic because it is difficult to replicate. Another 
classification, which is frequently used, is to include any condition listed in the international 
classification of diseases (ICD) chapter entitled “Congenital anomalies”. The ICD code alone does 
not differentiate between major and minor defects 
(http://apps.who.int/classifications/icd10/browse/2016/en#/XVII) and studies may suffer from 
problems associated with underreporting and/or variable reporting of minor defects. Classifications 
of birth defects can also be based on pathology or etiology rather than organ system (Wellesley et 
al. 2005). Furthermore, other systems used in dedicated birth defects registers could include 
reference to the classification system used by European Surveillance of Congenital Anomalies 
(EUROCAT) for example (http://www.eurocat-network.eu). These limitations show that the same 
classification and methodology should be used for subject groups that are compared in a specific 
study. In addition, as there are considerable differences in the reporting of minor birth defects, the 
inclusion of major birth defects only is preferable. Many studies include birth defects recorded in 
live-born children only. However, as many of the most severe birth defects may result in elective 
pregnancy termination, the total prevalence of birth defects, including those observed in terminated 
pregnancies, should be reported for all pregnancies, not just those following ART. Furthermore, if 
ART pregnancies are monitored more closely,such that birth defects are more likely to be detected 
prenatally, this may introduce bias in terms of differential case ascertainment between ART and 
non-ART births.  The direction of this bias may also depend on whether couples using ART are any 
more (or less) likely to undergo pregnancy termination of an affected fetus.  This important issue 
has not received much attention in the literature. A single study on congenital heart defects in 
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France showed no difference in either prenatal diagnosis or the termination of pregnancies 
between ART and non-ART births (Tararbit et al. 2015).   
 
Birth defects 
A higher rate of birth defects has been reported in children conceived through ART compared with 
children conceived naturally (Zhu et al. 2006; Pandey et al. 2012; Wen et al. 2012; Hansen et al. 
2013; Qin et al. 2015). From the meta-analysis by Hansen and coworkers, a 32% increased risk of 
birth defects in ART-children compared with SC infants (RR 1.32, 95% CI 1.24 to 1.42) was 
reported, and a slightly increased risk of 36% when singleton births were examined separately (RR 
1.36, 95% CI 1.30 to 1.43). When the studies were restricted to major birth defects, the increased 
risk was 42% (Hansen et al. 2013). An increased risk of defects was confirmed by the meta-
analysis of Qin and co-workers in 2015, which compared the risk for congenital birth defects in 
singleton ART-children with SC singletons (RR 1.37, 95% CI 1.29 to 1.45) (Qin et al. 2015). 
According to the cohort study by Davies, including close to 303,000 SC births and 6163 ART 
births, the increased risk of birth defects associated with standard IVF was no longer significant 
after adjustment for parental factors such as maternal age, parity, year of birth, maternal smoking 
during pregnancy and parental occupation (Davies et al. 2012). The risk of birth defects associated 
with ICSI remained increased after multivariable adjustment, although the possibility of residual 
confounding could not be excluded. Fresh IVF cycles were associated with a lower risk than fresh 
ICSI cycles. This is contrary to the findings of both Lie and Wen in their meta-analyses where ICSI 
did not increase the risk for birth defects compared with standard IVF (Lie et al. 2005; Wen et al. 
2012).  
A recent Nordic study including more than 90,000 ART children observed an increased risk 
although with a lower AOR for major birth defects, comparing singleton ART children with children 
born after SC (AOR 1.14, 95% CI 1.08 to 1.20). No difference was reported between ART twins 
and SC twins. During the time period 1988-2007, the RR of a major birth defect between ART-
children and SC-children remained unchanged with the most common birth defect being 
cardiovascular defects (Henningsen et al. 2018).  
A higher prevalence of genital malformations, including hypospadia, was found in singletons born 
to infertile couples after fertility treatment than in SC singletons (Zhu et al. 2006). Evidence 
suggests that men with testicular failure have an increased prevalence of chromosomal 
abnormalities (Bernardini et al. 2000; Dul et al. 2012) as well as cryptorchidism and testicular 
cancer (Olesen et al. 2017). The frequency of malformations in the genitourinary system, in 
particular hypospadias, has been reported to be about five times higher with ICSI using testicular 
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sperm (Fedder et al. 2007) compared with the risk of hypospadias in the general population 
(Toppari et al. 2001).   
Two systematic reviews (Holte et al. 2007; Woldringh et al. 2010) did not report any difference in 
the rate of birth defects in children conceived by ICSI using non-ejaculated sperm compared with 
ICSI using ejaculated sperm. However, most previous studies have compared pregnancy and 
neonatal outcome based on whether the spermatozoa originated from the testicle, the epididymis 
or from the ejaculate (Woldringh et al. 2011; Belva et al. 2011). The possible significance that the 
specific diagnosis of the azoospermic male partner has (e.g. obstructive azoospermia (OA), non-
obstructive azoospermia (NOA) or aspermia) on birth defect rate, however, has hardly been 
investigated. There was no difference in the major birth defect rate in children conceived when the 
fathers were diagnosed with NOA compared with OA or aspermia but the numbers were too small 
to be conclusive (Belva et al. 2011; Oldereid et al. 2014).  
The rate of birth defects in children born after FET with slow freezing procedures seems 
comparable to that of other ART children (Wennerholm et al. 2009; Pelkonen et al. 2014; 
Maheshwari et al. 2016). In the study by Belva and co-workers from 2008, a two-fold increase in 
rate of major malformations was reported in the children born after ICSI compared with IVF, and 
when compared with fresh transfer and ICSI (Belva et al. 2008). However, a more recent Belgian 
study reported that the prevalence of birth defects in singletons and twins born after embryo 
vitrification were similar to or slightly lower than after fresh ET (Belva et al. 2016b). 
 
Chromosomal anomalies 
A significantly higher rate of de novo, non-inherited chromosomal abnormalities in children born 
after ICSI was observed compared with the rate in the general population (1.6% versus 0.5%) 
(Bonduelle et al. 2002). When the father suffered from a reduced sperm concentration, the 
incidence of de novo abnormalities in the children was higher compared to children born to fathers 
with a normal sperm concentration (2.1% versus 0.24%, respectively) (Bonduelle et al. 2002). In 
another study, an increased risk for chromosomal anomalies seemed to be similar among different 
infertility groups, but was related to reduced sperm concentration and/or motility (Jozwiak et al. 
2004). However, the incidence of the de novo chromosomal anomalies was comparable in children 
conceived from non-ejaculated sperm versus ejaculated sperm, and also when comparing OA with 
NOA in a study of ICSI and 530 children conceived with testicular sperm, 194 with epididymal 





Possible mechanisms  
Whether this increase in birth defects with ART is attributable to patient characteristics related to 
infertility or to the IVF/ICSI technique is uncertain. Subfertility, with or without assisted conception, 
is significantly associated with a higher incidence of birth defects (Zhu et al. 2006; Davies et al. 
2012). Fertility treatment options in general (including standard IVF and ICSI, as well as IUI, 
hormone treatment, surgery and ‘alternatives’ i.e. treatments not usually pooled under the heading 
ART) were found to increase the risk of being diagnosed with a birth defect and the overall 
prevalence of birth defects increased with increasing time to pregnancy (Zhu et al. 2006).   
Severely impaired sperm count may rarely be explained by genetic causes such as microdeletions 
of the Y-chromosome, various chromosomal translocations, mutations of the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene or Klinefelter’s syndrome (Krausz 2011). 
However, there is still limited knowledge about the possible mutations and genes involved in male 
infertility (Bracke et al. 2018). ICSI is the method of choice for couples with severe male-factor 
infertility, giving these men the ability to become genetic fathers. With ART, these genetic 
abnormalities may be inherited from the infertile father as seen in fathers carrying a deletion in the 
Y chromosome (Kleiman et al. 1999).   
As with the effect observed for other adverse perinatal outcomes in ART infants, both infertility and 
ART treatment factors seem to contribute to the excess risk of birth defects after ART conceptions. 
It is difficult to obtain information about all individual aspects of ART treatment and their 
association with a certain birth defect, while holding all the other variables constant in sufficiently 
large studies (Hansen et al. 2013).  
 
Summary 
Subfertility as well as infertility treatment with or without ART is associated with a modestly 
increased risk of birth defects when compared with SC. On an individual level this increase in risk 




Psychomotor and language development, behavior and social functioning 
Three systematic reviews found comparable psychomotor development, overall social functioning, 
language development and behavior between children born after ART and SC controls (Middelburg 
et al. 2008; Bay et al. 2013b; Hart and Norman 2013b).   
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In a Danish National Birth Cohort study (n= 45, 557), SC singletons born of couples with an 
increased TTP showed a modest delay in psychomotor development compared with singletons 
born of fertile couples. Furthermore, infertility treatment was associated with a slight delay in some 
developmental milestones (Zhu et al. 2009).   
 
Cognitive development  
In the recent systematic review focusing on cognitive development following ART (Rumbold et al. 
2017) it was shown that most studies on the subject had methodological limitations, making it 
difficult to draw reliable conclusions. However, there was some high-quality evidence to suggest 
that certain ART treatments influence cognitive development (Stromberg et al. 2002; Knoester et 
al. 2008; Sandin et al. 2013).  
In a study including 5680 children born after IVF (3228 singletons), a four-fold increase (95% CI 
1.9 to 8.3) in risk of developmental delay and an increased risk of needing habilitation services 
[odds ratio (OR) 1.7, 95% CI 1.3 to 2.2] compared to SC children was reported (Stromberg et al. 
2002). However, when only singeltons were included, the increased risk of developmental delay 
was no longer significant (OR 2.0, 95% CI 0.7 to 5.4) although the OR was 2.0 and the risk of 
needing habilitation services in singletons was not significant (OR 1.4, 95% CI 1.0 to 2.1). In a 
Dutch study, ICSI singletons were shown to have significantly lower scores in tests of intelligence 
(on average 5–7 IQ points lower) compared with SC singletons. However, the number of children 
included was limited (ICSI n=83, IVF n=83) (Knoester et al. 2008).  
In a large prospective population-based registry study (n= 30,959 ART children), Sandin et al. 
found a small but significantly increased risk of mental retardation in ART children when compared 
to SC children (RR 1.18, 95% CI 1.01 to 1.36). When restricting the analysis to singletons the 
statistical significance disappeared. In a supplementary subanalysis in singletons, Sandin et al. 
found an association between mental retardation and ICSI-FET  (RR 2.36, 95% CI 1.04 to 5.36), 
but not between mental retardation and ICSI-fresh ET  (RR 1.60, 95% CI 1.00 to 2.57) (Sandin et 
al. 2013).  
Pinborg et al. reported no difference in risk of neurological deficits or special needs between 
IVF/ICSI children (singletons, n= 634) and SC children (Pinborg et al. 2003). Wagenaar et al. found 
no difference in cognitive function in 139 IVF conceived singletons aged 8-18 years when 
compared with SC singletons (Wagenaar et al. 2009) and Bay et al. reported a comparable risk of 
mental retardation in IVF conceived (n=139) and SC singletons (Bay et al. 2013a).  
A Danish study on academic performance, including 4766 adolescents born after ART, reported a 
higher crude mean test score in ART children (singletons and twins) compared to SC controls. 
However, for ART singletons the adjusted mean overall test score was slightly lower. No difference 
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was found in the adjusted analysis for twins (Spangmose et al. 2017) Similar results were found in 
a large population-based Swedish study of 8,323 ART singletons (Norrman et al. 2018). The effect 
of FET versus fresh ET on the school performance of children was reported in a recent Danish 
study from the same group and no differences were observed (Spangmose et al. 2018).  
 
Attention deficit hyperactivity disorder and autism spectrum disease 
Attention deficit hyperactivity disorder (ADHD) was found to be weakly associated with IVF in a 
Swedish study including 28,158 multiples and singletons born after IVF (OR 1.18, 95% CI 1.03 to 
1.36). However, after adjusting for length of involuntary childlessness the statistical significance 
was lost. Furthermore, no association was found when the analyses included only singletons 
(Kallen et al. 2011). A Danish study including 124,269 children born to women with fertility 
problems reported a significantly higher risk of ADHD [hazard ratio (HR) 1.36, 95% CI 1.29 to 1.45] 
in these children compared with children born to women without fertility problems, although no 
adjustments were made for multiple gestations (Svahn et al. 2015).  
When adjusted for multiplicity, analyses reported by Hvidtjørn et al. (n= 33,139) and later Sandin et 
al. (n=30,959) found no increased risk of autism spectrum disease (ASD) for ART treatment overall 
(Hvidtjorn et al. 2011; Sandin et al. 2013). Fountain et al. (Fountain et al. 2015) identified an 
elevated incidence of diagnosed ASD amongst 48,865 Californian multiples and singletons 
conceived by ART. However, the adjusted risk was not elevated among singletons alone. From the 
same Californian cohort, Kissin et al. reported a higher risk of ASD in ICSI singletons compared to 
standard IVF with fresh ET (adjusted hazard risk ratio (HRR) 1.65, 95% CI 1.08 to 2.52) (ART 
singletons n= 19,790 (Kissin et al. 2015).  
In a recent meta-analysis Liu et al. concluded that ART was associated with a greater risk of ASD 
when comparing the complete ART group with SC children (RR 1.35, 95% CI 1.09 to 
1.68, P = 0.007). However, in the subgroup analysis for singletons only there was no increased risk 
of ASD (RR 0.94, 95% CI 0.77 to 1.14) (Liu et al. 2017).   
 
Cerebral palsy 
An increased risk of cerebral palsy (CP) was found for singletons compared with naturally 
conceived controls in a Swedish study including 5680 children born after IVF (OR 2.8, 95% CI 1.3 
to 5.8) (Stromberg et al. 2002). In another Swedish study including 16,280 children born after IVF 
(multiples and singletons), a higher risk for CP was found in the crude analysis but disappeared 
after adjustment for year af birth, maternal age, parity, smoking and years of unwanted 
childlessness (AOR 1.14, 95% CI 0.72 to 1.81) (Kallen et al. 2005). An increased risk for CP found 
among 33,139 IVF children (HR 2.34, 95% CI 1.81 to 3.01) in a Danish study disappeared when 
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adjusted for multiplicity and GA (Hvidtjorn et al. 2010). Another Danish study found an increased 
risk of CP in singletons after fresh ET, but not FET, compared to SC (AOR 2.44, 95% CI 1.15 to 
5.22, P =0.02) (Pinborg et al. 2010).   
In a recent Australian register study including 2914 children born after ART, the prevalence of CP 
was more than doubled in ART singletons at <32 weeks GA compared to SC singletons at <32 
weeks GA (AOR 2.7, 95% CI 1.0 to 6.9) (Goldsmith et al. 2018).   
 
Summary 
For most neurodevelopmental health variables conflicting results exist concerning a possible 
association with ART. Many of the identified risk associations disappeared after adjustment for 
multiple births or were only observed in subgroups.  
 
Cardiovascular function and metabolism 
Higher cardiovascular and metabolic risk profiles in ART offspring is of importance for individuals 
as well as for society, as this may influence the health of future generations. As ART is still a 
relatively new technology the follow-up time is limited to childhood and early adulthood, with limited 
numbers of children in the older age cohorts, and the studies are based on few cases with mostly 
small and highly selected control groups.  
Cardiovascular and metabolic profiles of offspring conceived by ART have been summarized in a 
systematic review (Hart and Norman 2013a) and also recently reported in a systematic review and 
meta-analysis (Guo et al. 2017). The (Hart and Norman 2013a)  systematic review concludes that 
the limited data on ART offspring suggest a potential increase in blood pressure (BP), elevated 
fasting glucose and increase in total body fat composition (Hart and Norman 2013a). The recent 
meta-analysis included 19 studies with a total of 2,112 IVF/ICSI and 4,096 SC offspring and 
concluded that systolic BP (SBP) and diastolic BP (DBP) were higher in ART than in SC offspring 
(weighted mean differences (WMD): 1.88; 95% CI 0.27 to 3.49 for SBP and 1.51; 95%CI 0.33 to 
2.70 for DBP) (Guo et al. 2017). However, the higher WMD in SBP and DBP was only observed in 
the cohorts born in 1990-1999 and not for those born in 2000-2009 and was not linked to bias 
introduced by younger participants or a larger ICSI proportion in the younger cohorts. ART 
stimulation protocols and techniques have improved over the two timeperiods; milder ovarian 
stimulation, single embryo transfer and the laboratory tecniques have developed. These are all 
changes that may cause less epigenetic modification at the gamete and embryonal stages.  
Meta-analyses showed comparable BMI, low-density lipoprotein, cholesterol and fasting insulin 
levels for ART and SC children (Guo et al. 2017).  
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Cardiovascular function was reported in five studies including 50-128 ART children and 50-100 SC 
controls in the age range 1 month to 12 years (Guo et al. 2017). Owing to the heterogeneity in the 
methods used to assess cardiovascular function, no meta-analysis was performed on this 
outcome. A consistently suboptimal cardiac diastolic function was reported in all studies especially 
under stressful conditions such as high altitude(Scherrer et al. 2012; Valenzuela-Alcaraz et al. 
2013; Zhou et al. 2014; Liu et al. 2015; von Arx et al. 2015). Two studies showed higher aortic and 
carotid intima-media thickness among ART offspring (Scherrer et al. 2012; Valenzuela-Alcaraz et 
al. 2013)  
Recently, a Swiss follow-up of the Scherrer et al. 2012 study, including adolescents aged 16-17 
years found that the average BP and BP variability were markedly higher in ART-conceived 
adolescents than in SC controls(Meister et al. 2018). Eight of 52 ART participants, but only one of 
the 43 controls had arterial hypertension (BP > 130/80) (Meister et al. 2018). 
 
Summary 
Limited data suggest a potential increase in BP and deteriorated metabolic profiles in ART children 
as well as suboptimal cardiovascular function. 
 
Growth 
Ceelen et al. assessed the growth from birth to 8-18 years in 233 ART versus SC children and 
observed a rapid catch-up growth from birth, which gave rise to concern as rapid growth is 
associated with an increased risk of disease later in life, in particular cardiovascular disease 
(Barker 2007; Ceelen et al. 2009).  
Although children born after ART are more likely to be born preterm, most studies have shown 
similar growth patterns in ART and SC children (Hart and Norman 2013b; Chen and Heilbronn 
2017). A recent US prospective follow-up study compared 969 singletons conceived after fertility 
treatment (ART and ovulation induction +/- IUI) with 2,471 SC children and found comparable 
growth and development up to 3 years of age (Yeung et al. 2016) and similar observations have 
been seen in European cohorts (Olivennes et al. 1997; Bonduelle et al. 2005; Basatemur et al. 




Although we recognize the paucity of studies, the overall results on growth in children born after 




Respiratory and allergic disorders 
Both PTB and LBW are known as risk factors for asthma (Jaakkola et al. 2006). A Swedish registry 
study of 2,628,728 children born in 1982-2007 and including 31,918 conceived by ART revealed an 
increased risk for asthma in children born after ART (AOR 1.28, 95% CI 1.23 to 1.34), increasing 
the absolute risk from 4.4% to 5.6% (Kallen et al. 2013). The risk was higher for preterm than term 
singletons. The effect of IVF on the risk of asthma was low and statistically non-significant for 
children with a low Apgar score, respiratory diagnoses, mechanical ventilation, continuous positive 
airway pressure or neonatal sepsis. Adjustment for the duration of infertility eliminated the effect, 
and removal of infants whose mothers had used anti-asthmatic drugs in early pregnancy reduced 
the risk.  
A UK-wide prospective study, the Millennium Cohort Study, of 18,818 singletons recruited at 9 
months of age was based on a follow-up survey at 5 years of age (response rates of 79 and 70%, 
respectively). Children born to subfertile parents were found to be more likely to experience 
asthma (AOR 1.39, 95%CI 1.07 to 1.80), wheezing (AOR 1.27, 95 %CI 1.00 to 1.63) and to be 
taking anti-asthmatic drugs at 5 years of age (AOR 1.90, 95% CI 1.32 to 2.74) compared with SC 
children (Carson et al. 2013).The association was mainly related to children born after ART (AOR 
2.65, 95% CI 1.48 to 4.76; AOR 1.97, 95% CI 1.10 to 3.53 and AOR 4.67, 95% CI 2.20 to 9.94 for 
asthma, wheezing and taking anti-asthmatics, respectively). However, only 104 children conceived 
by ART were included in the study. Although diminished, the association was also present in 7-
year-old children. The data were adjusted for a wide range of possible confounding and mediating 
factors and data were weighted for non-response to minimize any selection bias.   
 
Summary 
The main risk factor for the association between asthma and ART is parental subfertility, but 




Only a few large cohort studies with sufficient power concerning risk assessment for malignancies 
currently exist. In a population-based British cohort study from 2013, including 106,013 ART 
children, no increase in the overall risk of cancer was found when compared with the expected risk 
standardized incidence ratio (SIR) for singleton births (1.04, 95% CI 0.80 to 1.33) (Williams et al. 
2013). A retrospective population-based cohort study combining data from four Nordic countries 
(CoNARTaS) including 91,796 children (singletons and multiples) born after ART also concluded 
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that there was no increase in overall cancer rates when compared with children born after SC; 
adjusted HR 1.08 (95% CI 0.91 to 1.27) (Sundh et al. 2014). No adjustments were made for 
plurality. In a study from Israel including a cohort of 9,042 children conceived after ART and 
211,763 SC children born from 1997 to 2004, no elevated risk for overall types of cancer in 
singletons (RR 1.32, 95% CI 0.80 to 2.17) was found (Lerner-Geva et al. 2017). In a Norwegian 
study including 25,782 children conceived after ART, where 51 cases of cancers were observed, 
the HR of cancer in ART versus the control population was 1.21 (95% CI 0.90 to 1.63) (Reigstad et 
al. 2016). Maternal use of fertility drugs and risk for cancer was examined in a cohort of 123,322 
children in a Danish study from 2015 (Hargreave et al. 2015). No increased risk for cancer was 
found in childhood (HR 0.94, 95% CI 0.60 to 1.46) or in young adulthood (HR 0.89,95% CI 0.36 to 
2.24)) after maternal use of fertility drugs. No adjustments were made for plurality.  
In line with the results found in children born after non-donor ART (described above), a recent 
study identified no overall increased risk of cancer in a cohort of 12,137 children born after donor 
ART (donor oocytes, sperm or embryos); standardized incidence ratio for singletons 0.91 (95% CI 
0.37 to 1.87) (Williams et al. 2018).  
 
Summary 
Large cohort studies consistently show no increased risk of overall cancer in children conceived by 
ART. However, studies on specific cancers are very limited by sample size. 
 
Reproductive health   
The first study exploring semen quality in the oldest ICSI offspring cohort was reported recently. 
The authors found that among 54 young adult men conceived by ICSI because of severe male 
infertility, the median sperm concentration, total sperm count, and total motile sperm count were 
significantly lower than in SC men, even after adjusting for relevant confounders. The young ICSI 
men were almost three times more likely to have sperm concentrations <15 million/ml and four 
times more likely to have total sperm count <39 million. However, no clear correlation between 
semen parameters of the young ICSI men and their fathers was found (Belva et al. 2016a). In 
another study, the same group showed that reproductive hormones in these young adult ICSI men 
(n = 54) were comparable to SC controls (Belva et al. 2017a). In a cohort of young adult women 
conceived by ICSI because of male factor infertility (n = 71), the antral follicle count, and anti-
Müllerian hormone (AMH), FSH, LH, and dehydroepiandrosterone (DHEAS) levels in serum (were 





The limited data published on reproductive health in ART offspring indicate some deterioration in 
sperm counts in male offspring conceived by ICSI, while in female offspring no adverse effects 
have been identified. 
 
Controlled ovarian stimulation 
Few studies report perinatal outcome and controlled ovarian stimulation (COS) regimens. In a 
large trial (MERIT trial) comparing recombinant FSH and urinary hMG (Andersen et al. 2006), there 
were no apparent differences between highly purified hMG and recombinant FSH with respect to 
neonatal health among live-born children. Follow up studies from RCTs (Bonduelle et al. 2012) and 
a Cochrane review (Pouwer et al. 2015) compared long-acting FSH versus daily FSH. In all, 806 
children were assessed in the follow-up analysis 
(Bonduelle et al. 2012) and they found that the PTB rate was 8.3% and 9.3% in the long-acting 
FSH and conventional daily FSH group, respectively, while LBW rates were 6.6% and 6.8%, 
respectively. Major birth defects were in the expected range and did not differ between the groups 
(Bonduelle et al. 2012).  
Few studies, with contradictory results, have investigated whether the number of oocytes retrieved 
after COS might be associated with negative perinatal outcomes. A large cohort study from the UK 
including more than 65,000 singleton births after IVF found an association between excessive 
ovarian response (>20 oocytes retrieved for IVF) to COS and an increased risk of PTB and LBW 
(Sunkara et al. 2015). However, another study investigating factors affecting obstetric outcome 
after IVF found no association between VLBW or SGA and the number of oocytes retrieved, 
although fewer deliveries were included (Sazonova et al. 2011). COS for IVF that results in a high 
serum estradiol (E2) peak on the day of administration of hCG, as opposed to a more moderate 
rise in E2, has been found to be a risk factor for LBW (Pereira et al. 2015). Finally, a large registry 
study from Sweden including 27,000 singletons from fresh cycles found no indication of an adverse 
perinatal outcome associated with the number of oocytes retrieved (Magnusson et al. 2018).  
 
Summary 
The data on the impact of COS, although limited with respect to different COS regimes and 








At the beginning of the IVF era the individual IVF laboratories produced their own culture media 
whereas nowadays a number of different commercially available culture media are used, and 
although a description of the media components is made available by the manufacturers, the exact 
composition is often not revealed (Sunde et al. 2016). Further, the type of culture media used in a 
specific ART cycle is only rarely recorded in ART registers, which has also hampered research into 
the safety of this aspect of ART.  
 
In 2010, Dumoulin et al. published the first data suggesting that culture media (Vitrolife Gl.3 versus 
Cook K-SIMC) influenced the BW of singletons conceived by ART with fresh transfer of cleavage 
stage embryos (BW±SEM: Vitrolife Gl.3 3453±53g versus CooK-SIMC 3208±61g; P=0.003). 
Subsequent prospective studies from the Dutch group with random allocation to two culture media 
groups showed a similar BW of the infants and altered growth patterns of the fetus from the second 
trimester of pregnancy and at 2 years of age between the different culture media (Dumoulin et al. 
2010; Nelissen et al. 2012; Kleijkers et al. 2014). A recent Dutch study observed that two culture 
media were associated with differences in body weight, BMI, truncal adiposity, waist circumference 
and waist/hip ratio in 9-year-old children conceived after ART, while no significant differences were 
observed regarding cardiovascular development (Zandstra et al. 2018). Two other studies showed 
culture medium-dependent differences in mRNA expression levels of genes involved in apoptosis, 
protein degradation, metabolism and cell-cycle regulation (Kleijkers et al. 2015a) and that the age 
of the embryo culture media was inversely associated with the BW of singletons born after ART 
(Kleijkers et al. 2015b). In 2016, Kleijkers et al. published a multicenter, double-blind RCT of 836 
couples comparing human tubal fluid (HTF) with Vitrolife G5 embryo culture media and confirmed 
their finding of an association between culture media and BW ( HTF group versus G5 group: mean 
difference of 158g, 95% CI 42 to 275g), and for singletons alone the Z-score was significantly 
elevated after adjustment for GA and gender (Kleijkers et al. 2016).  
 
On the other hand, seven retrospective cohort studies and one RCT found no difference between 
two different culture media in terms of BW of the infants after transfer of cleavage stage embryos. 
However, the retrospective studies all have methodological limitations and the RCT included only 







Few prospective, controlled studies indicate that some embryo culture media may affect the BW of 
children conceived by ART.  
 
Culture time 
Compared to cleavage stage culture (day 2-4), blastocyst culture (day 5-6) implies an extended in-
vitro embryo culture time that goes beyond embryonic genomic activation, potentially having 
adverse effects on the embryo and offspring. Furthermore, the culture media used for the extended 
culture period differ from those used for growth to cleavage stage (Sunde et al. 2016). A possible 
advantage of an extended culture period is a self-selection of the most viable embryo, which 
potentially may result in more healthy infants born after transfer of blastocysts rather than cleavage 
stage embryos. 
Three systematic reviews and meta-analyses on perinatal outcomes after transfer of blastocyst 
versus cleavage stage embryo have been published recently (Martins et al. 2016; Wang et al. 
2017; Alviggi et al. 2018). Alviggi et al. and Wang et al. included 14 and 12 studies, respectively, 
and the analyses were performed for singletons with stratified analyses on fresh cycles, frozen 
cycles and both fresh and frozen cycles. Martin et al. included 12 studies with singletons after both 
fresh and frozen cycles. All three meta-analyses included more than 100,000 singletons and found 
a significantly higher rate of PTB (<37 weeks of gestation) (RR 1.12-1.16) and VPTB (<32 weeks 
of gestation) (RR 1.14-1.16) after blastocyst compared to cleavage stage transfer. There was no 
difference with respect to LBW or VLBW. However, the risk of SGA was significantly lower for 
infants born after blastocyst transfer (RR 0.83-0.84) (Martins et al. 2016; Wang et al. 2017; Alviggi 
et al. 2018). Regarding LGA, the meta-analysis, which pooled fresh and frozen cycles (Martins et 
al. 2016; Wang et al. 2017), found an increased risk after blastocyst transfer (RR 1.12 (95%CI 1.03 
to1.21), while the the two meta-analysis including only fresh cycles found no significant association 
[RR 1.22 (95%CI 1.00 to1.48) and RR 1.14 (95%CI 0.97 to 1.35)] (Wang et al. 2017; Alviggi et al. 
2018) . Two of the three reviews included birth defects and found no increased risk of birth defects 
after extended culture time (Martins et al. 2016; Alviggi et al. 2018).  
The causes of the increased risk of PTB after blastocyst transfer are not clear, but the possibility of 
genetic and epigenetic changes in the trophectoderm cells resulting in abnormal placentation and 
implantation has been considered and has raised concerns. Still, one must keep in mind that the 
results above are based on retrospective observational studies with high heterogeneity and that 
relevant confounder adjustment has not been performed.   
In an extensive review, Wale and Gardner (Wale and Gardner 2016) have pointed out that during 
in-vitro culturing the embryo is constantly exposed to stressors, which are not present in-vivo. In 
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the IVF laboratory, chemical and physical factors (e.g. incubator gases, temperature, pH, oxygen 
concentration, culture oils, the act of pipetting itself) not related to the culture medium and culture 
time per se may also have potentially adverse effect on embryos. Hence it is crucial to investigate 
the impact of these factors in order to optimize the in-vitro environment. 
The risk of monozygotic (MZ) twinning after blastocyst transfer compared to cleavage stage 
embryo transfer was studied by Hviid et al. in a systematic review including 38 studies with a rate 
of MZ twins from zero to 13.3%. Their meta-analysis showed an elevated risk after blastocyst 
transfer compared with cleavage stage ET (OR 2.18, 95% CI 1.93 to 2.48). The authors pointed 
out that the underlying mechanism for the increased risk of MZ twinning is not fully understood and 
besides extended culture time, culture media and maternal age, the authors hypothesized that the 
age of the oocytes may also be a potential risk factor for MZ twinning after ART (Hviid et al. 2018).  
 
Summary  
Studies suggest that an extended culture time for embryos is associated with an increased risk of 
some adverse perinatal outcomes, particularly PTB. Further a higher rate of MZ twinning has been 
observed after culture to blastocyst stage.  
 
Number of embryos transferred 
 
In ART singleton pregancies with a vanishing twin the risk of PTB is increased and furthermore, 
there is a higher risk of CP that increases the later in pregnancy the spontaneous reduction occurs 
(Pinborg et al. 2005). Thus, the consequences of multiple ET are not only observed in twin 
pregnancies but also in singleton deliveries, where the loss of a twin occurs in one in ten 
pregnancies in case of a DET policy (Pinborg et al. 2005). Most ART twins originate from DET and 
the considerable increased short- and long-term risks in ART twins should encourage a SET policy 
as the bench marking standard, as one fresh ET + one frozen ET results in similar live birth rates 
tot DET (Thurin et al. 2004; Thurin-Kjellberg et al. 2009). With the improved freezing programs, 
SET should be the gold standard as DET mainly adds a risk to both singleton and twin offspring 
and does not improve cumulative live birth rates.  
A large UK cohort study showed that the vanishing twin phenomenon is associated with an 
increased risk of PTB and LBW in the surviving singletons conceived after ART (Kamath et al. 
2018).  The same study showed that when a single gestational sac was seen at ultrasonography 




Oocyte donation and gestational surrogacy 
Oocyte donation 
The number of OD treatments has increased over time. Nowadays in Europe, more than 40,000 
transfers are performed using donated oocytes and 63 % of the recipients are 40 years or older 
(Calhaz-Jorge et al. 2017). In the USA, more than 20,000 donor oocyte ETs are performed yearly 
with the percentage of cycles increasing sharply after age 40 years (CDC 2015).  
 
It is well known that there is an increased risk of obstetric and perinatal complications after OD 
treatment. The rate of HDP is 16-40 %, which is two to three times higher than in standard IVF/ICSI 
pregnancies (van der Hoorn et al. 2010; Malchau et al. 2013; Nejdet et al. 2016; Savasi et al. 2016; 
Masoudian et al. 2016; Storgaard et al. 2017). Several studies have also shown that the risk of PTB 
and LBW is increased two- to three-fold more often after OD compared to standard IVF conception 
(Adams et al. 2015; Nejdet et al. 2016; Storgaard et al. 2017). Only a few studies have reported 
rates on birth defects after OD, with no differences found compared to autologous IVF (Soderstrom-
Anttila et al. 1998; Malchau et al. 2013).  
The high occurrence of obstetric complications after use of donated oocytes has been associated 
to the couples´s infertility, primiparity and to advanced maternal age. This is probably not the only 
explanation because young oocyte recipients have similar rates of HDP to women of more 
advanced age (Keegan et al. 2007). One hypothesis is that in these HDP pregnancies the 
genetically foreign fetus induces immunological reactions and placental pathology, such as villitis, 
chronic deciduitis, and ischemic changes, in the oocyte recipient (Gundogan et al. 2010; van der 
Hoorn et al. 2010; Savasi et al. 2016). Lashley et al. suggested that HLA matching between donor 
and recipient might prevent the immunologic mismatch between mother and fetus thereby 
decreasing the risk of HDP and other obstetric and perinatal complications (Lashley et al. 2015).  
 
Gestational surrogacy  
The transfer of an embryo originating from a genetically foreign oocyte also occurs in gestational 
surrogacy (GS). However, the rate of HDP has generally been reported to be much lower (between 
4.3 and 10 %) in singleton GS pregnancies compared to that in OD pregnancies (Parkinson et al. 
1999; Dar et al. 2015; Soderstrom-Anttila et al. 2016). In a large dataset comparing outcomes after 
GS and autologous IVF, there was no increased risk of PTB, LBW or birth defects after GS 
compared to autologous IVF (Sunkara et al. 2017). Based on the limited data on GS outcome 
available, there has been speculation that a healthy carrier with a normal reproductive background 
might somehow compensate for perinatal risks associated with a foreign embryo and IVF. The 
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surrogates might have a more hospitable uterine environment than infertile oocyte recipients 
(Gibbons et al. 2011).   
In a recent study pregnancy complications and perinatal outcomes were compared in live born 
singletons conceived with the use of embryos from intended parents (n =103) versus SC (n = 249) 
carried in the same woman (Woo et al. 2017). Children born after GS had a lower mean 
gestational duration, higher rates of PTB (10.7% versus 3.1%, respectively), and higher rates of 
LBW (7.8% versus 2.4%, respectively). The authors concluded that the results showed that ART 
may potentially affect embryo quality and that even a proven healthy uterine environment cannot 
compensate for this negative impact (Woo et al. 2017). However, many factors might have affected 
the study outcome, for example an artificial replacement cycle versus natural cycle, number of 
embryos transferred, and the time interval between the SC and surrogate pregnancies (Spandorfer 
2017).  
 
Long-term follow up  
Surprisingly, there are only a few long-term follow-up studies on the health of OD children. In a 
Finnish follow-up study of 164 children born after OD and aged 1-14 years, the incidence of severe 
neurological disability was 1.8%. Nine children (5.5%) had a diagnosis of an endocrine or 
autoimmune disease, including premature adrenarche, diabetes, growth delay, hypothyreosis, 
parathyroid disorder, juvenile rheumatitis and coeliac disease (Soderstrom-Anttila et al. 2010).  
 
Summary 
Perinatal outcomes are poorer for singletons conceived after OD compared to both singletons 
conceived after autologous IVF and SC. The extent to which the poorer perinatal outcomes after 
OD relates to immunological factors associated with a genetically foreign oocyte or to other 
confounding factors, such as advanced maternal age, maternal co-morbidity, uterine environment 
and ART laboratory procedures, is unknown. Pregnancies achieved through OD are high-risk 




One rapidly expanding field in ART is the use of frozen oocytes. Reports from OD programmes 
using young donors show similar clinical pregnancy rates after transfer of embryos created from 
fresh or vitrified oocytes (Cobo et al. 2008; Cobo et al. 2010). As mentioned earlier, concern has 
arisen regarding the oocyte vitrification procedure and its possible health risks for the offspring 
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(Cobo et al. 2014). The main worries are associated with use of the high concentrations of 
cryoprotectants that are required to avoid ice crystal formation in the oocytes.  
 In 2009, Noyes et al. reported data on 936 infants born after use of either slow-freezing or 
vitrification of autologous or donor oocytes. Data were gathered from 23 case reports, 35 case 
series and from seven fertility centers around the world. As the multiple birth status was not well 
reported, the PTB and LBW rate could not be properly assessed.  In all, 1.3% (12/936) had a birth 
defect, the most common of which was a ventricular septal defect. The birth defect rate was 1.1% 
after slow freeze and 1.5% after the use of vitrified embryos, similar to that reported in SC children 
(Noyes et al. 2009).  
 
The largest set of data to date included approximately 1000 children born after vitrification of donor 
oocytes (88%) or own oocytes (12%) (Cobo et al. 2014). Of the infants born, 43% originated from 
multiple pregnancies. No differences in GA, BW, Apgar scores, birth defects, and perinatal 




Perinatal outcomes after oocyte vitrification are reassuring, although the evidence is scarce. There 





Genome-wide epigenetic reprogramming occurs during gametogenesis and early embryogenesis 
(Inbar-Feigenberg et al. 2013). Epigenetic marks are erased in the primordial germ cells (the 
precursor cells of sperm and oocytes). Subsequently, epigenetic reprogramming occurs before and 
after fertilization, including parent-of-origin controlled activity of specific genes (genomic 
imprinting). Many imprinted genes are found in clusters on chromosomes and some genes are 
expressed from the paternally inherited allele and others from the maternally inherited allele 
(Ferguson-Smith 2011). Differentially methylated regions in imprinted genes are protected from the 
global wave of demethylation that occurs in the early embryo during preimplantation development 
(Feng et al. 2010). Epimutation refers to an aberrant DNA methylation or histone modification 
pattern (Horsthemke 2010) (Fig. 4). A majority of imprinting defects are primary epimutations, 
which occur in the absence of DNA mutation (Horsthemke 2010).  
26 
 
Genetic factors in infertile couples and the variables involved in ART (hormones, culture media, 
prolonged embryo culture, cryopreservation) may have adverse effects on these epigenetic 
processes, which are then transmitted to the offspring (Horsthemke and Ludwig 2005; Ceelen et al. 
2008; Jiang et al. 2017). After ART, changes in DNA methylation and/or transcription of some 
transposable elements and imprinted genes were found in placenta samples while transcription 
modifications for some transposable elements were also discovered in cord blood (Choux et al. 
2018). Song and coworkers compared placental DNA methylation levels at 37 CpG sites in 16 
previously identified candidate genes in SC children and ART children conceived either from 
autologous oocytes or from donor oocytes obtained from young, healthy, fertile donors. Significant 
differences in placental DNA methylation levels were demonstrated between the donor oocyte ART 
and fertile control groups. The authors concluded that the observed methylation differences seem 
to be associated with some aspect of the ART procedures, not simply the underlying infertility 
(Song et al. 2015). A recent Finnish study on human placentas looked at DNA methylation 
changes together with phenotypic findings and suggested that an intronic rs10732516 
polymorphism, which is in the sixth binding site for CCCTC-binding factor in the H19 imprinting 
control region,,associates with the effects of ART in a parent-of-origin manner. The authors 
conclude that this polymorphism should be considered when the effects of environmental factors 
on embryonic development are studied (Marjonen et al. 2018).   
Indirect supporting data on epigenetic programming comes from epidemiological and animal 
studies. Periconceptional exposure to famine during the Dutch Hunger Winter in 1944-45 was 
associated, six decades later, with less DNA methylation of the imprinted insulin growth factor 2 
gene (IGF2) in individuals conceived at that time compared to their unexposed siblings (Heijmans 
et al. 2008). Epigenetic change in the IGF2 receptor (IGFR2) gene was associated with fetal 
overgrowth after sheep embryo culture, although the mechanism was not analogous to Beckwith-
Wiedemann syndrome (BWS) in humans (Young et al. 2001). In addition, superovulation has been 
shown to perturb genomic imprinting of both maternally and paternally expressed genes in a 
mouse model (Market-Velker et al. 2010).   
 
Imprinting disorders  
Imprinting disorders currently comprise a group of 12 rare congenital diseases that are defined by 
phenotype and/or an association with molecular disturbances at specific imprinted loci (Soellner et 
al. 2017). A majority of these disorders are characterized by aberrant pre- and/or postnatal growth, 
hypo- or hyperglycemia, abnormal feeding behavior in early childhood and later, behavioral 




A systematic review and meta-analysis by Lazaraviciute and coworkers has demonstrated an 
excess of imprinting disorders in children born after IVF and ICSI (Lazaraviciute et al. 2014). The 
combined OR (95%CI) of any imprinting disorder in children born after ART was 3.67 (1.37 to 9.74) 
compared to SC children. Their results regarding the methylation within individual imprinted genes 
were inconclusive owing to the small number of studies and their heterogeneity. In a registry study, 
Lidegaard and coworkers compared the frequency of imprinting diseases in 6052 children born 
after IVF with the incidence in 442,349 SC children born in 1995-2001 in Denmark (Lidegaard et al. 
2005) and no increased risk of imprinting disorders after IVF was detected.  
 
BWS is associated with abnormalities in imprinted genes at 11p15.5 (Soellner et al. 2017). Using 
eight epidemiological studies, Vermeiden and Bernardus found a positive association between 
IVF/ICSI and BWS with a RR of 5.2, 95%CI 1.6 to 7.4 (Vermeiden and Bernardus 2013). They 
calculated that with the population prevalence of 1:13,700, among every 2700 IVF/ICSI births one 
BWS child would be born. In BWS primary epimutations at the imprinting control center 2 (IC2) 
have been associated with ART (Dias and Maher 2013). Tenorio and coworkers carried out a 
molecular analysis and obtained complete data regarding conception for 156 patients with clinical 
features of BWS from The Spanish Overgrowth Syndrome Registry (17 born after ART, 139 after 
SC). They demonstrated that the chance of having an epimutation at 11p15 was 7.18 times higher 
in patients with BWS born after ART than in those born after SC (Tenorio et al. 2016).  
 
Silver-Russell syndrome (SRS) is a clinical mirror of BWS, also associated with imprinted genes at 
11p15.5 (Soellner et al. 2017). Up to 50% of children with SRS have hypomethylation of the 
paternal IC1 resulting in silencing of both alleles of IGF2. Vermeiden and Bernardus suggested a 
positive association of SRS with IVF or ISCI, but data were too sparse to draw a conclusion 
(Vermeiden and Bernardus 2013). Several sporadic reports have been published linking SRS with 
ART (Cocchi et al. 2013).  
 
Prader–Willi syndrome (PWS) and Angelman syndrome (AS) are caused by a deficiency in 
imprinted gene expression from the paternal or maternal chromosome 15q11-q13, respectively, 
and the patients display different phenotypes (Camprubi et al. 2007). A subgroup (1-4%) of PWS 
and AS patients has an imprinting defect, the majority of which is associated with epimutation 
(Buiting et al. 2003). Vermeiden and Bernardus found no associations between the incidence of AS 
and PWS and IVF or ICSI treatments (Vermeiden and Bernardus 2013). Johnson and coworkers 
detected one AS patient with an imprinting error in a series of prenatal samples from 949 IVF 






Imprinting disorders have been associated with ART but discriminating the influence of the 
variable ART procedures per se and the effect of the reproductive disease of the parents 




The chicken or the egg? 
The choice of a proper comparison group for children born after ART is a challenge. Most studies 
have used groups of children born of healthy, fertile women in the general population as controls 
thus making it difficult to separate the contribution of infertility per se from the ART treatment (i.e. 
the chicken or the egg). However, a variety of different approaches have been carried out to 
explain the gap between the outcomes of singletons conceived by ART and SC.  
 
Subfertility and sibling studies 
In a systematic review and meta-analysis, singletons born after ART were compared with SC 
singletons of subfertile women with pregnancy TTP >1 year with the inclusion of six studies 
(Pinborg et al. 2013). Two of the papers were included in a meta-analysis of PTB, showing a 
pooled AOR of 1.55 (95% CI 1.30 to 1.85).  
A large cohort study compared ART singletons (n = 10,149) and a subfertile population (n = 8,054) 
used as reference with a fertile population (n = 441,420). Risks for adverse infant outcomes were 
increased for the ART group with adjusted risks ranging from 1.21 to 1.26 for LBW and PTB, 
respectively, and 1.40 to 1.44 for VLBW and VPTB, respectively (Luke et al. 2017). Risks were 
lower for the fertile population than for the subfertile population for all outcomes.  
Another approach has been to study potential differences in outcome related to causes of infertility. 
In a review, Luke analysed the effect of infertility diagnoses (male factor, endometriosis, ovulation 
disorders, tubal factors, inflammation). Women with an infertility-related diagnosis, who conceived 
with or without ART had higher risks for adverse perinatal outcomes compared to women without 
an infertility diagnosis. This gives support for the primary role of the underlying infertility disorder 
rather than the ART treatment in causing the increased risk of adverse perinatal outcome (Luke 
2017). The chance of conceiving naturally with regard to the cause of infertility is poorly explored. 
Thus, the absolute indications for fertility treatment are still not well defined. With the great number 
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of underlying reasons for subfertility and the gap in knowledge about impact of these on adverse 
outcomes, caution must be taken if grouping all types of subfertility into one category.  
When adjusting for “years of infertility” as a simple confounder, there is a risk of effect modification, 
therefore studies that do use this adjustment should instead perform a stratified analyses 
comparing risk in ART versus non-ART couples and using subgroups of women with 1-2 years of 
subfertility, 2-3 years and 4-5+ years. In addition, subgroups of treated women have been studied 
by comparing “low technology treatment” (IUI) with ART and SC (Wang et al. 2002). A 50% 
increased risk of PTB in the IUI group and a two-fold higher risk in the ART group were found 
(Wang et al. 2002). In a meta-analysis, PTB in singletons born after ovulation induction and/or IUI 
were compared with SC singletons, where TTP was ≤ 1 year. The results showed a higher risk of 
PTB in the low technology treatment group (AOR 1.45, 95% CI 1.21 to 1.74), indicating that 
infertility per se is an important factor in ART outcome (Pinborg et al. 2013).   
 
Sibling studies 
Comparisons of siblings that are discordant for mode of conception have been used in 
observational studies. In the sibship design, where a mother gives birth to both one singleton 
conceived by ART and one singleton conceived by SC, the mothers are their own controls and 
adjustment can be made for changes in maternal age and parity between the two deliveries and 
birth order. In this design, factors such as biology (genetics), lifestyle, and socio-economic situation 
are relatively constant during a woman’s reproductive life. Thus, the major strength of this design is 
the steadiness of maternal and paternal factors.  
A meta-analysis of PTB in ART versus SC siblings including two Nordic studies showed an 
increased risk for PTB in the ART sibling (AOR 1.27, 95% CI 1.08 to 1.49), indicating a risk 
attributable to the ART treatment per se (Pinborg et al. 2013). A sibship study from the USA also 
showed that subfertile women, with or without ART, were at increased risk for adverse perinatal 
outcomes when compared with fertile women (Luke et al. 2016). Women whose fertility status 
declined from their first to their second singleton pregnancy had increased risks for adverse 
outcomes, and the highest risks were observed in those women with the steepest decline in their 
fertility status (Luke et al. 2016). Thus, subfertility plays a significant role in the adverse outcome in 
ART although it is not the only contributor. Recently, potential limitations to the sibling comparisons 
have been debated (Frisell et al. 2012). First, the fact that siblings may not share the same 
environment (i.e. that a mother may change life style behaviour between pregnancies) cannot 
always be measured and can therefore bias the results. This risk of bias is one of the limitations 
that are being discussed and it has been claimed that it is the nonsystematic aspects of the 
unshared environment that are the most difficult to measure and therefore tend to be uncontrolled.  
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On the other hand, others claim that a sibling design is appropriate as evidence suggests that the 
unshared environmental factors contribute only little to the interindividual variation in the outcome 
of interest (Keyes et al. 2013). In a recent UK study looking at cognitive development following 
ART, the authors highlighted the methodological considerations regarding the choice of 
comparison group and confounding and mediating factors (Carson et al. 2010). Cognitive 
development test scores in ART children at the age of 3 years was increased, but was explained 
by the women treated with ART having higher socioeconomic status and longer education than 
women that did not have ART treatment. The authors emphasized that the comparison groups 
should be carefully selected with regard to the study question one aims to address, and further 
variables should be considered as a potential confounder or mediating factor as this can help to 
identify the underlying mechanism of an observed association. For future studies, discussion of 
potential biases that accompany evolving study designs will continue to improve the quality of the 
research and the use of the sib-ship design will give further insight to the “chicken or the egg” 
debate.   
 
Summary 
Singletons born of subfertile women are preferable as the control group for ART singletons, as 
infertility per se is a contributing factor to the adverse outcomes in the ART offspring. Future 
research is needed on the comparability of subfertile couples that eventually conceive naturally 
and couples conceiving by the use of ART. To identify a potential effect of the reproductive 
technology per se, the sib-ship design may contribute, given that the important limitations of the 




Future research  
We still have a considerable gap in knowledge concerning the long-term health of children 
conceived by ART and we need to explore the influence of different ART methods, including the 
freezing of embryos and other laboratory procedures, on the long-term health outcomes. In order 
to cover this field, both epidemiological and clinical research is needed; international and national 
databases and registry studies that combine ART cycle data with health care information (i.e. 
hospital diagnosis codes, drug prescription registries and specific registries on childhood diabetes 
and malignancies) with the possibility of linking the parents to the child can elucidate some of the 
questions in the coming years.  
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However, large clinical studies with thorough medical investigations of the children including 
cardiometabolic (e.g. BP, right and left cardiovascular function), endocrine and reproductive 
function (e.g. deterioration in sperm count in ICSI offspring) and epigenetic mapping are necessary 
to fully investigate the long-term health consequencs and underlying mechanisms responsible for 
the possible negative influence of ART. Other areas that need further research are 
neurodevelopmental health (increased risk of CP, ASD and mental retardation in ICSI offspring), 
male infertility diagnosis (e.g. azoospermia) and risk of birth defects in ICSI, the consequences of 
the chosen stimulation regimen, and the effect of different culture media and culture time. The 
exact composition of the commercial media ought to be available for future research. Furthermore, 
during in-vitro culture other chemical and physical factors, besides media and time, could have an 
impact on the offspring and should be investigated. Moreover, differences between ART and non-
ART parents in life style factors, such as smoking and BMI, may also bias the health outcome risks 
in ART children and should be included as a confounding factors in future research.  
In general, this research will help us to understand the influence of early changes in the embryo 
and foetal environment on later development. A research programme such as this requires 
resources and these should be prioritized and facilitated in the reproductive, medical and political 
spheres, both at a national and international level.    
 
Conclusion 
In general, the short-term health of singletons conceived by ART shows modestly increased risks 
of adverse outcomes, including LBW, PTB and birth defects. Studies on long-term health are still 
too sparse to allow robust conclusions to be reached.  Limited data indicate that cardiovascular 
and metabolic risk profiles may be altered after ART.  
The surveillance of ART children by ART registries and national health care registries are of utmost 
importance for monitoring the long-term health of children conceived by ART and to monitor the 
health of children born after the introduction of new ART techniques, such as preimplantation 
genetic testing, vitrification and blastocyst transfer.  
The causes of the poorer outcomes seem to be a combination of parental subfertility and the ART 
techniques per se. However, the multiple pregnancies after ART are still by far the most important 
contributor to adverse health outcomes in ART offspring and we should not lose focus on 
recommending SET. In spite of this knowledge, twin and higher-order multiple pregnancy rates are 
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Figure 1 Factors with a possiple adverse effect on the offspring born after ART.  
 
Figure 2 Perinatal outcomes in singletons born after ART versus singletons born without ART. 
 
Outcomes are depicted as bars showing the adjusted risks (x-axes) with 95% CI (error bars).  
PTB: preterm birth, LBW: low birthweight, SGA: small for gestational age, PNM: perinatal mortality 
 
Figure 3 Time trends in preterm birth rates. 
A. Time trends in preterm birth rates among children (singletons and twins) born after ART in four 
Nordic countries.   
B. Time trends in preterm birth rates according to plurality in children born after ART and naturally 
in four Nordic countries.  
 
Figure 4 Basic epigenetic mechanisms involved in the regulation of gene expression and 
development.  
Figure 6 Factors affecting the short- and long-term health in offspring born after ART. 
 
 
 
 
 
